SCHEMBL16932053

SCHEMBL16932053

Cc1ccc(S(=O)(=O)O)cc1.Fc1cccnc1

nearest known ligand 0.54

Known targets — ChEMBL curated mechanism

ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ EGFR known ✓ P00533 1/20 0.49
▸ NAPRT Q6XQN6 1/20 0.54
▸ ALDH1A1 P00352 3/20 0.54
▸ LMNA P02545 2/20 0.54
▸ MAPT P10636 2/20 0.54
▸ TDP1 Q9NUW8 2/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ HTT P42858 1/20 0.54
▸ PTGS2 P35354 2/20 0.49
▸ POLB P06746 1/20 0.47
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ NAMPT P43490 2/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28728504 1.00 NAPRT (0.54) NAPRTALDH1A1LMNAMAPTTDP1
3-Methylpyridine SCHEMBL5743407 0.85 NAPRT (0.59) NAPRTALDH1A1LMNAMAPTTDP1
Pyridine SCHEMBL25354696 0.81 NAPRT (0.69) NAPRTALDH1A1LMNAMAPTTDP1
SCHEMBL20815908 0.80 ALDH1A1 (0.51) ALDH1A1LMNAMAPTTDP1SMN1; SMN2
Pyridine SCHEMBL2126952 0.80 ALDH1A1 (0.58) NAPRTALDH1A1LMNAMAPTTDP1
Pyridine SCHEMBL20958 0.80 ALDH1A1 (0.58) NAPRTALDH1A1LMNAMAPTTDP1
Pyridine SCHEMBL7656088 0.80 ALDH1A1 (0.58) NAPRTALDH1A1LMNAMAPTTDP1
Pyridine SCHEMBL6427981 0.80 ALDH1A1 (0.58) NAPRTALDH1A1LMNAMAPTTDP1
Pyrimidine SCHEMBL2352439 0.80 MAPT (0.58) NAPRTALDH1A1LMNAMAPTTDP1
Pyridine SCHEMBL31483849 0.80 ALDH1A1 (0.58) NAPRTALDH1A1LMNAMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250216782-A1 MASKING PROCESS USING SWITCHABLE POLYMER TOKYO ELECTRON LTD (JP) 2025-07-03 — — US claimed
US-9541834-B2 Ionic thermal acid generators for low temperature applications ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2017-01-10 — — US claimed
US-20250216782-A1 MASKING PROCESS USING SWITCHABLE POLYMER TOKYO ELECTRON LTD (JP) 2025-07-03 — — US disclosed
CN-109541886-B Antireflective compositions, methods of use thereof, and coated substrates 罗门哈斯电子材料韩国有限公司 2022-04-26 — — CN disclosed
US-10429737-B2 Antireflective compositions with thermal acid generators ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2019-10-01 — — US disclosed
US-20190085173-A1 ANTIREFLECTIVE COMPOSITIONS WITH THERMAL ACID GENERATORS DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2019-03-21 — — US disclosed
US-9541834-B2 Ionic thermal acid generators for low temperature applications ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2017-01-10 — — US disclosed
US-9209028-B2 Ion implantation methods ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2015-12-08 — — US disclosed
US-20150212414-A1 IONIC THERMAL ACID GENERATORS FOR LOW TEMPERATURE APPLICATIONS ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2015-07-30 — — US disclosed
US-20150214056-A1 ION IMPLANTATION METHODS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2015-07-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190085173-A1 ANTIREFLECTIVE COMPOSITIONS WITH THERMAL ACID GENERATORS ASIC1, ASIC3, ASF1A EGFR 3257/4885NAPRT 948/4885ALDH1A1 149/4885
US-10429737-B2 Antireflective compositions with thermal acid generators ASIC1, ASIC3, ASF1A EGFR 3257/4885NAPRT 948/4885ALDH1A1 149/4885
US-20150212414-A1 IONIC THERMAL ACID GENERATORS FOR LOW TEMPERATURE APPLICATIONS TRIM4, TRMT1, TRIM59 EGFR 2600/4885NAPRT 27/4885ALDH1A1 1833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback